Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection-Reference-Cited by-同舟云学术

Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection

Published:2011-04-24 Issue:5 Volume:43 Page:482-486
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Ford Christopher B,Lin Philana Ling,Chase Michael R,Shah Rupal R,Iartchouk Oleg,Galagan James,Mohaideen Nilofar,Ioerger Thomas R,Sacchettini James C,Lipsitch Marc,Flynn JoAnne L,Fortune Sarah M

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/ng.811.pdf

Reference31 articles.

1. Balcells, M.E., Thomas, S.L., Godfrey-Faussett, P. & Grant, A.D. Isoniazid preventive therapy and risk for resistant tuberculosis. Emerg. Infect. Dis. 12, 744–751 (2006).

2. Cattamanchi, A. et al. Clinical characteristics and treatment outcomes of patients with isoniazid-monoresistant tuberculosis. Clin. Infect. Dis. 48, 179–185 (2009).

3. Denver, D.R., Morris, K., Lynch, M. & Thomas, W.K. High mutation rate and predominance of insertions in the Caenorhabditis elegans nuclear genome. Nature 430, 679–682 (2004).

4. Haag-Liautard, C. et al. Direct estimation of per nucleotide and genomic deleterious mutation rates in Drosophila. Nature 445, 82–85 (2007).

5. Lynch, M. et al. A genome-wide view of the spectrum of spontaneous mutations in yeast. Proc. Natl. Acad. Sci. USA 105, 9272–9277 (2008).

Cited by 382 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent efforts in the development of glycoconjugate vaccine and available treatment for tuberculosis;Bioorganic Chemistry;2024-09

2. Onset of infectiousness explains differences in transmissibility acrossMycobacterium tuberculosislineages;2024-08-27

3. Mycobacterium tuberculosis is less likely to acquire pathogenic mutations during latent infection than during active disease;Microbiology Spectrum;2024-07-02

4. Mycobacterial biofilms: A therapeutic target against bacterial persistence and generation of antibiotic resistance;Heliyon;2024-06

5. Unraveling tuberculosis patient cluster transmission chains: integrating WGS-based network with clinical and epidemiological insights;Frontiers in Public Health;2024-05-20